U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: March 27 - April 2, 2022
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: March 27 - April 2, 2022

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner of Food and Drugs

Event Date: 03/28/2022
Location: Virtual
Subject: Clinical Trials Transformation Initiative Executive Committee Meeting
FDA Participant/Group: ROBERT TEMPLE; BRAM ZUCKERMAN; MOHAMMED ELZARRAD;
Non FDA Participant/Group: Clinical Trials Transformation Initiative Committee members and staff

Event Date: 03/31/2022
Location: New York, NY
Subject: 2022 STAT Breakthrough Science Summit
FDA Participant/Group: MICHAEL FELBERBAUM;
Non FDA Participant/Group: Industry, academia, media and other invited guests

Event Date: 04/01/2022
Location: Virtual
Subject: Public Health Policy at FDA
FDA Participant/Group: N/A
Non FDA Participant/Group: Thomas Frieden (Resolve To Save Lives);

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

Event Date: 03/28/2022
Location: Virtual
Subject: Researching COVID to Enhance Recovery Initiative Executive Committee Meeting
FDA Participant/Group: PETER MARKS;
Non FDA Participant/Group: Government, academia, industry and other invited attendees

Event Date: 03/30/2022
Location: Virtual
Subject: Accelerating COVID-19 Therapeutic Interventions and Vaccines Leadership and Team Meeting
FDA Participant/Group: PETER STEIN; PETER MARKS;
Non FDA Participant/Group: Parties involved in Accelerating COVID-19 Therapeutic Interventions and Vaccines

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 03/28/2022
Location: Virtual
Subject: United States and Canada Joint Committee on Food Safety Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several staff from the Canadian Food Inspection Agency and Health Canada

Event Date: 03/31/2022
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA Staff
Non FDA Participant/Group: Several members from the Sustainable Food Policy Alliance

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Jacqueline O'Shaughnessy, Acting Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 03/29/2022
Location: Virtual
Subject: Naloxone Public Meeting
FDA Participant/Group: MARTA SOKOLOWSKA;
Non FDA Participant/Group: Susan C. Winckler (Reagan-Udall Foundation for the FDA); Josh Bolin (National Association of Boards of Pharmacy); Nabarun Dasgupta (University of North Carolina); Jeffrey Bratberg (The University of Rhode Island); Bobby Mukkamala (American Medical Association);

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 03/31/2022
Location: Virtual
Subject: All Matters FDA - 12th Annual and Food Drug Law Symposium; Speaker, COVID-19 Vaccines
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the All Matters FDA - 12th Annual Food and Drug Law Symposium

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 03/28/2022
Location: Virtual
Subject: General Medical Device Updates
FDA Participant/Group: ANN FERRITER; FRANCISCO VICENTY; TIMOTHY STENZEL; MARIANELA PEREZ-TORRES; ERIN KEITH; KELLIE KELM; OWEN FARIS; WILLIAM MAISEL; RICHARD CHERRY; COURTNEY LIAS; ANNE REID; KEISHA THOMAS; JOYCE WHANG;
Non FDA Participant/Group: Tom Polen, Ami Simunovich, Elizabeth McCombs, David Sha, William Sigmund, Elizabeth Woody, Mark O’Donnell, Adrienne Brott and Brad Spring (Becton, Dickinson and Company)

Event Date: 03/30/2022
Location: Washington, DC
Subject: FDA User Fee Reauthorization Hearing: Ensuring Safe and Effective Medical Devices
FDA Participant/Group: N/A
Non FDA Participant/Group: Health Subcommittee, House Energy and Commerce

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Michele Mital, Acting Director, Center for Tobacco Products

Event Date: 03/29/2022
Location: Virtual
Subject: Tobacco Merchants Association (TMA) 2022 Conference; Keynote Address: Update from FDA’s Center for Tobacco Products
FDA Participant/Group: MITCHELL ZELLER;
Non FDA Participant/Group: Members of the Tobacco Merchants Association

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

Event Date: 03/28/2022
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: WILLIAM FLYNN; ANTONIA MONIQUE SENNETT;
Non FDA Participant/Group: Members of the American Association of Bovine Practitioners and American Association of Swine Veterinarians

Official Name: Tucker Patterson, Ph.D., Acting Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

Back to Top